These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19061727)

  • 21. Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence.
    Mallette FA; Goumard S; Gaumont-Leclerc MF; Moiseeva O; Ferbeyre G
    Oncogene; 2004 Jan; 23(1):91-9. PubMed ID: 14712214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cdk2: a key regulator of the senescence control function of Myc.
    Hydbring P; Larsson LG
    Aging (Albany NY); 2010 Apr; 2(4):244-50. PubMed ID: 20445224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers.
    Wallerand H; Robert G; Pasticier G; Ravaud A; Ballanger P; Reiter RE; Ferrière JM
    Urol Oncol; 2010; 28(5):473-9. PubMed ID: 19272800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What has senescence got to do with cancer?
    Dimri GP
    Cancer Cell; 2005 Jun; 7(6):505-12. PubMed ID: 15950900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
    Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
    Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer-associated S100P protein binds and inactivates p53, permits therapy-induced senescence and supports chemoresistance.
    Gibadulinova A; Pastorek M; Filipcik P; Radvak P; Csaderova L; Vojtesek B; Pastorekova S
    Oncotarget; 2016 Apr; 7(16):22508-22. PubMed ID: 26967060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis.
    Hagiyama H; Adachi T; Yoshida T; Nomura T; Miyasaka N; Honjo T; Tsubata T
    Oncogene; 1999 Jul; 18(28):4091-8. PubMed ID: 10435590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C; Guo F; Xu G; Ma J; Shao F
    Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14(ARF)-MDM2-p53 axis.
    Van Maerken T; Vandesompele J; Rihani A; De Paepe A; Speleman F
    Cell Death Differ; 2009 Dec; 16(12):1563-72. PubMed ID: 19779493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumorogenesis and mdm2 protein].
    Flores C; Sobrevia L
    Rev Med Chil; 2000 May; 128(5):539-46. PubMed ID: 11008360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.
    DeYoung MP; Johannessen CM; Leong CO; Faquin W; Rocco JW; Ellisen LW
    Cancer Res; 2006 Oct; 66(19):9362-8. PubMed ID: 17018588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
    Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
    Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence.
    Larsson LG
    Semin Cancer Biol; 2011 Dec; 21(6):367-76. PubMed ID: 22037160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deregulating EMT and senescence: double impact by a single twist.
    Smit MA; Peeper DS
    Cancer Cell; 2008 Jul; 14(1):5-7. PubMed ID: 18598938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential extension of proliferative lifespan in human fibroblasts induced by over-expression of CDK4 or 6 and loss of p53 function.
    Morris M; Hepburn P; Wynford-Thomas D
    Oncogene; 2002 Jun; 21(27):4277-88. PubMed ID: 12082615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells.
    Slack AD; Chen Z; Ludwig AD; Hicks J; Shohet JM
    Cancer Res; 2007 Mar; 67(6):2448-55. PubMed ID: 17363562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort?
    Montserrat N; Gallardo A; Escuin D; Catasus L; Prat J; Gutiérrez-Avignó FJ; Peiró G; Barnadas A; Lerma E
    Hum Pathol; 2011 Jan; 42(1):103-10. PubMed ID: 20970163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PML is induced by oncogenic ras and promotes premature senescence.
    Ferbeyre G; de Stanchina E; Querido E; Baptiste N; Prives C; Lowe SW
    Genes Dev; 2000 Aug; 14(16):2015-27. PubMed ID: 10950866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence.
    Reimann M; Lee S; Loddenkemper C; Dörr JR; Tabor V; Aichele P; Stein H; Dörken B; Jenuwein T; Schmitt CA
    Cancer Cell; 2010 Mar; 17(3):262-72. PubMed ID: 20227040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.